• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病、代谢综合征和心血管危险因素。一项基于人群的研究。

Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.

机构信息

Institut de Recerca Biomèdica de Lleida (IRB Lleida), Lleida, Spain.

Dermatology Department, Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain.

出版信息

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):128-135. doi: 10.1111/jdv.15159. Epub 2018 Jul 17.

DOI:10.1111/jdv.15159
PMID:29953676
Abstract

BACKGROUND

Psoriasis is a very prevalent systemic chronic inflammatory disease. Major cardiovascular events are the main cause of mortality in these patients which suggests an association between psoriasis and traditional cardiovascular risk factors.

OBJECTIVE

To identify classic cardiovascular risk factors and metabolic syndrome (MS) in patients with psoriasis, their possible association with its severity and compare it with the non-psoriatic population.

METHODS

This is an observational and cross-sectional population study in Lleida (Spain) from a joint hospital/primary care database.

RESULTS

The database comprised 398 701 individuals. There were 6868 cases registered as psoriasis (1.7%), and 499 of them (7.3%) were classified as moderate-severe psoriasis. Patients with psoriasis had a higher prevalence of traditional cardiovascular risk factors than non-psoriatic population: diabetes mellitus 2 (13.9% vs 7.4%, OR 2.01), dyslipidaemia (28.8% vs 17.4%, OR 1.92), arterial hypertension (31.2% vs 19.0%, OR 1.93), obesity (33.7% vs 28.1%, OR 1.30), altered fasting basal glycaemia (21.4% vs 15.1%, OR 1.54), low cholesterol HDL (38.1% vs 32.3%, OR 1.29), hypertriglyceridaemia (45.7% vs 35.2%, OR 1.55) and high waist circumference (75.7% vs 72.3%, OR 1.19). MS was more prevalent in psoriatic patients (28.3% vs 15.1%, OR 2.21), and cardiovascular risk factors were similar between psoriasis severity groups. Psoriatic patients had a higher prevalence of ischaemic heart disease (3.3% vs 1.8%, OR 1.87) and vascular cerebral accidents (1.8% vs 1.2%, OR 1.55). A model for MS showed a significant nonlinear relationship with age and sex and significant differences between patients with and without psoriasis.

CONCLUSION

We found statistically significant differences in relation to the prevalence of cardiovascular risk factors, MS and major cardiovascular events in psoriatic patients. However, differences were not seen between psoriasis severity groups. Our work reinforces the need for a multidisciplinary approach and close monitoring of cardiovascular risk factors in these patients to prevent a cardiovascular event.

摘要

背景

银屑病是一种非常普遍的系统性慢性炎症性疾病。主要心血管事件是这些患者死亡的主要原因,这表明银屑病与传统心血管危险因素之间存在关联。

目的

确定银屑病患者的经典心血管危险因素和代谢综合征(MS),及其与疾病严重程度的可能关联,并与非银屑病人群进行比较。

方法

这是一项在西班牙莱里达(Lleida)进行的基于医院/初级保健数据库的观察性、横断面人群研究。

结果

数据库共包含 398701 人。登记了 6868 例银屑病(1.7%)病例,其中 499 例(7.3%)为中重度银屑病。与非银屑病人群相比,银屑病患者具有更高的传统心血管危险因素患病率:糖尿病 2 型(13.9% vs 7.4%,OR 2.01)、血脂异常(28.8% vs 17.4%,OR 1.92)、动脉高血压(31.2% vs 19.0%,OR 1.93)、肥胖(33.7% vs 28.1%,OR 1.30)、空腹基础血糖升高(21.4% vs 15.1%,OR 1.54)、胆固醇高密度脂蛋白(HDL)降低(38.1% vs 32.3%,OR 1.29)、高甘油三酯血症(45.7% vs 35.2%,OR 1.55)和高腰围(75.7% vs 72.3%,OR 1.19)。银屑病患者的 MS 更为常见(28.3% vs 15.1%,OR 2.21),且不同疾病严重程度组的心血管危险因素相似。银屑病患者缺血性心脏病(3.3% vs 1.8%,OR 1.87)和脑血管意外(1.8% vs 1.2%,OR 1.55)的患病率更高。MS 的模型显示出与年龄和性别之间的显著非线性关系,以及有和无银屑病患者之间的显著差异。

结论

我们发现银屑病患者的心血管危险因素、MS 和主要心血管事件的患病率存在统计学显著差异。然而,不同疾病严重程度组之间没有差异。我们的工作加强了对这些患者进行多学科管理和密切监测心血管危险因素的必要性,以预防心血管事件的发生。

相似文献

1
Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.银屑病、代谢综合征和心血管危险因素。一项基于人群的研究。
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):128-135. doi: 10.1111/jdv.15159. Epub 2018 Jul 17.
2
Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.银屑病患者皮肤表现严重程度和年龄对多种心血管危险因素患病率的影响。
J Eur Acad Dermatol Venereol. 2012 Mar;26(3):348-53. doi: 10.1111/j.1468-3083.2011.04076.x. Epub 2011 May 4.
3
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.法国银屑病患者的代谢合并症和高血压。与法国国家数据库的比较。
Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8.
4
Factors influencing cardiometabolic risk profile in patients with psoriasis.影响银屑病患者心脏代谢风险状况的因素。
Australas J Dermatol. 2018 May;59(2):e93-e98. doi: 10.1111/ajd.12577. Epub 2017 Feb 27.
5
Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study.慢性斑块状银屑病患者代谢综合征及心血管改变的患病率及其与疾病严重程度的相关性:一项基于医院的横断面研究。
Indian J Dermatol Venereol Leprol. 2016 Sep-Oct;82(5):510-8. doi: 10.4103/0378-6323.183638.
6
Cardiovascular Risk Factors and Carotid Intima-Media Thickness in a Colombian Population With Psoriasis.哥伦比亚银屑病患者的心血管危险因素与颈动脉内膜中层厚度
Actas Dermosifiliogr. 2017 Oct;108(8):738-745. doi: 10.1016/j.ad.2017.04.015. Epub 2017 Jun 27.
7
Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.中年立陶宛成年人的严重血脂异常及相关危险因素:一项横断面队列研究。
Lipids Health Dis. 2018 Apr 19;17(1):88. doi: 10.1186/s12944-018-0731-7.
8
Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study.需要系统治疗的西班牙银屑病患者的代谢综合征:一项横断面研究PSO-RISK中代谢综合征的患病率及其与心血管疾病的关联
J Dermatolog Treat. 2015;26(4):318-25. doi: 10.3109/09546634.2014.983039. Epub 2014 Nov 28.
9
Metabolic syndrome and psoriasis: a study in 97 patients.代谢综合征与银屑病:一项针对97例患者的研究。
Rev Assoc Med Bras (1992). 2018 Apr;64(4):368-373. doi: 10.1590/1806-9282.64.04.368.
10
Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.银屑病患者的代谢综合征、C反应蛋白与心血管风险:一项横断面研究
An Bras Dermatol. 2018 Mar;93(2):222-228. doi: 10.1590/abd1806-4841.20186397.

引用本文的文献

1
Association between Life's Crucial 9 and psoriatic arthritis in U.S. adults: a cross-sectional study.美国成年人中生命关键9要素与银屑病关节炎之间的关联:一项横断面研究。
Front Med (Lausanne). 2025 Aug 7;12:1574896. doi: 10.3389/fmed.2025.1574896. eCollection 2025.
2
The Kynurenine Pathway in Psoriasis: Mechanisms and Therapeutic Opportunities.银屑病中的犬尿氨酸途径:机制与治疗机遇
Inflammation. 2025 Jul 21. doi: 10.1007/s10753-025-02339-9.
3
Cardiovascular Risk Among Patients With Moderate-to-Severe Plaque Psoriasis in Southern Sri Lanka: A Case-Control Study.
斯里兰卡南部中重度斑块状银屑病患者的心血管风险:一项病例对照研究。
Cureus. 2025 May 29;17(5):e85057. doi: 10.7759/cureus.85057. eCollection 2025 May.
4
A diagnostic prediction model for cardiovascular diseases (CVDs) in patients with psoriasis.银屑病患者心血管疾病(CVDs)的诊断预测模型。
Front Cardiovasc Med. 2025 May 26;12:1584305. doi: 10.3389/fcvm.2025.1584305. eCollection 2025.
5
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
6
The prognostic impact of stress hyperglycemia ratio for all-cause mortality in patients with Psoriasis.银屑病患者应激性高血糖比值对全因死亡率的预后影响。
Sci Rep. 2024 Oct 30;14(1):26113. doi: 10.1038/s41598-024-77019-z.
7
Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study.美国成年人生命必需的八项指标与银屑病之间的关联:一项横断面研究。
Front Med (Lausanne). 2024 Oct 10;11:1445288. doi: 10.3389/fmed.2024.1445288. eCollection 2024.
8
Sex Differences in Moderate to Severe Psoriasis: Analysis of the Psoriasis Longitudinal Assessment and Registry.中重度银屑病的性别差异:银屑病纵向评估与注册研究分析
J Psoriasis Psoriatic Arthritis. 2022 Jul;7(3):132-139. doi: 10.1177/24755303221099848. Epub 2022 May 3.
9
Clinical Implications of Metabolic Syndrome in Psoriasis Management.代谢综合征在银屑病管理中的临床意义
Diagnostics (Basel). 2024 Aug 14;14(16):1774. doi: 10.3390/diagnostics14161774.
10
Cardiovascular Considerations and Implications for Treatment in Psoriasis: An Updated Review.心血管问题的考虑因素及对银屑病治疗的影响:最新综述。
Vasc Health Risk Manag. 2024 May 10;20:215-229. doi: 10.2147/VHRM.S464471. eCollection 2024.